YM Biosciences issues $15-million floatation

Guest Contributor
June 21, 2002

YM Biosciences Inc has raised $15 million with the floatation of 3.75 million shares on the Toronto Stock Exchange and the Alternative Investment Market of the London Stock Exchange. The Mississauga-based YM will use the proceeds to expand and accelerate its product pipeline and commercial focus. The firm was formed to acquire the rights to develop drug products from a variety of research sources, with a focus on oncology. It has four products in clinical development, a fifth approved for trials and may acquire a sixth....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.